Inj Semaglutide 0 point 25 mg,Inj Paclitaxel 100 mg,Inj Filgrastim 300 mcg,Tab Combipack of Nerupit
Indian Army
HYDERABAD, TELANGANA
Progress
Quantity
18
Category
Inj Serplulimab 300mg
Bid Type
Two Packet Bid
The Indian Army, Department of Military Affairs, seeks a supplier for five injectable medicines: Inj Serplulimab 300mg, Inj Paclitaxel 100 mg, Inj Carboplatin 150 mg, Inj Filgrastim 300 mcg, and Inj Leuprolide 22.5 mg. The BOQ lists 5 items but does not disclose explicit quantities, unit names, or a defined estimated value. The contract scope is limited to the supply of goods, with an option clause allowing up to 25% quantity variation at contract award and during currency at contracted rates. The award will rely on bid price and compliance with purchaser terms, with delivery linked to original and extended periods.
Option Clause allows ±25% quantity adjustment at contract and during currency
Delivery period starts from last date of original delivery order; extension rules apply
Scope is limited to supply of goods; no installation or service obligations stated
Not explicitly described in tender data; bidders should expect standard procurement terms and confirm payment schedule in bid
Delivery period originates from the last date of the original order; extended delivery time calculated by (additional quantity/original quantity) × original period, minimum 30 days
Not specified in provided terms; bidders must verify LD provisions during bid submission
Demonstrate capability to supply injectable oncology medications
Provide OEM authorization where applicable
Meet regulatory/licensing requirements for distribution of chemotherapeutic agents
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
Inj Serplulimab 300mg , Inj Paclitaxel 100 mg , Inj Carboplatin 150 mg , Inj Filgrastim 300 mcg , Inj Leuprolide 22 point 5mg
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
HYDERABAD, TELANGANA
N/a
SAHIBGANJ, JHARKHAND
Directorate Of Health Services Kashmir
BUDGAM, JAMMU & KASHMIR
Indian Army
KOLKATA, WEST BENGAL
Indian Army
KOLKATA, WEST BENGAL
Tender Results
Loading results...
Inj Serplulimab 300mg
inj
Inj Paclitaxel 100 mg
inj
Inj Carboplatin 150 mg
inj
Inj Filgrastim 300 mcg
inj
Inj Leuprolide 22 point 5mg
inj
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Inj Serplulimab 300mg | inj | 3 | no | ms18473f | 21 | |
| 2 | Inj Paclitaxel 100 mg | inj | 3 | no | ms18473f | 21 | |
| 3 | Inj Carboplatin 150 mg | inj | 3 | no | ms18473f | 21 | |
| 4 | Inj Filgrastim 300 mcg | inj | 6 | no | ms18473f | 21 | |
| 5 | Inj Leuprolide 22 point 5mg | inj | 3 | no | ms18473f | 21 |
Discover companies most likely to bid on this tender
GST registration certificate
PAN card
Experience certificates for similar supply of injectable pharmaceuticals
Financial statements (last 3 years) demonstrating financial capability
EMD/Security deposit proof as per buyer terms
Technical bid documents detailing product compliance and packaging
OEM authorization letters for each listed drug (if bidding as distributor)
Any regulatory approvals or licenses for import/manufacture and distribution
Key insights about TELANGANA tender market
Bidders must submit GST registration, PAN, experience certificates, financial statements, EMD proof, and OEM authorizations. Provide a technical bid detailing product compliance for Inj Serplulimab, Paclitaxel, Carboplatin, Filgrastim, and Leuprolide, along with delivery timelines under the 25% quantity option clause.
Eligibility requires demonstrated capability to supply injectable oncology medicines, regulatory licenses for distribution, and OEM authorizations if bidding as a distributor. Provide prior experience in similar pharmaceutical procurements and financial stability documentation as part of the bid.
Mandatory documents include GST certificate, PAN card, three years of financial statements, experience certificates for similar supply, EMD proof, technical bid with product compliance, and OEM authorizations for each drug if applicable.
Delivery can be increased up to 25% at contract; extended delivery time is calculated by (additional quantity/original quantity) × original period, with a minimum of 30 days, and may extend to the original delivery period during extension.
The tender lists five injectables by name and dosage; no explicit ISO or GMP codes are provided in the data. Bidders should show regulatory approvals and packaging compliance for each drug variant in the technical bid.
Payment terms are not stated in the provided data; bidders should confirm payment schedule in the bid and align with standard government procurement timelines, including submission of compliant invoices after delivery.
Scope is explicitly limited to the supply of goods only; no installation or service components are described. Bidders should ensure their bid covers all costs for supplying the five listed injectables.
Check for OEM authorization letters in the bid package; if bidding as distributor, provide current manufacturer authorization for each drug and confirm regulatory licenses that authorize distribution of these injectable medicines.
Indian Army
📍 HYDERABAD, TELANGANA
Employees State Insurance Corporation (esic)
📍 AHMEDABAD, GUJARAT
Border Security Force (bsf)
📍 DHALAI, TRIPURA
Border Security Force (bsf)
📍 KACHCHH, GUJARAT
Indian Navy
📍 MUMBAI, MAHARASHTRA
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS